HCA Healthcare, Inc. (NYSE:HCA) is Pinnacle Financial Partners Inc's 10th Largest Position

Pinnacle Financial Partners Inc cut its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 255,844 shares of the company's stock after selling 5,865 shares during the quarter. HCA Healthcare comprises about 2.1% of Pinnacle Financial Partners Inc's portfolio, making the stock its 10th biggest position. Pinnacle Financial Partners Inc owned approximately 0.10% of HCA Healthcare worth $103,983,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in HCA Healthcare by 0.4% in the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company's stock worth $5,666,569,000 after acquiring an additional 60,304 shares in the last quarter. Capital World Investors increased its stake in HCA Healthcare by 57.5% during the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company's stock valued at $931,342,000 after purchasing an additional 1,019,750 shares in the last quarter. Darsana Capital Partners LP grew its holdings in shares of HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company's stock valued at $369,472,000 after buying an additional 400,000 shares during the last quarter. TD Asset Management Inc raised its stake in HCA Healthcare by 2.7% in the 2nd quarter. TD Asset Management Inc now owns 741,130 shares of the company's stock worth $238,110,000 after acquiring an additional 19,812 shares during the last quarter. Finally, Epoch Investment Partners Inc. grew its stake in HCA Healthcare by 16.4% during the 2nd quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company's stock valued at $203,002,000 after purchasing an additional 88,948 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

Shares of HCA traded down $1.21 during trading hours on Wednesday, hitting $349.32. 1,433,137 shares of the stock were exchanged, compared to its average volume of 1,180,307. HCA Healthcare, Inc. has a 12-month low of $233.23 and a 12-month high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The stock's 50-day moving average price is $387.95 and its two-hundred day moving average price is $357.16. The company has a market cap of $88.48 billion, a price-to-earnings ratio of 15.72, a price-to-earnings-growth ratio of 1.35 and a beta of 1.68.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.76%. HCA Healthcare's dividend payout ratio is presently 11.85%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Wells Fargo & Company upped their target price on HCA Healthcare from $395.00 to $400.00 and gave the company an "equal weight" rating in a research report on Wednesday, November 6th. Morgan Stanley initiated coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They set an "equal weight" rating and a $427.00 target price for the company. Barclays cut their price target on HCA Healthcare from $396.00 to $392.00 and set an "overweight" rating on the stock in a research report on Friday, November 8th. Royal Bank of Canada lifted their price target on HCA Healthcare from $378.00 to $405.00 and gave the company an "outperform" rating in a research report on Friday, August 23rd. Finally, Wolfe Research raised shares of HCA Healthcare to a "strong-buy" rating in a research note on Thursday, August 29th. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $385.00.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the firm's stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company's stock, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.60% of the company's stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.